ArticleAnnals of surgical oncology2025

Methodological Concerns Regarding: "Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?"

Magnus Glindvad AhlströmPubMed ↗Publisher ↗

No numbers read from the abstract.